MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. [PDF]
Kotch C +3 more
europepmc +1 more source
A giant multinodular plexiform schwannoma of the brachial plexus: Differential diagnosis, multidisciplinary treatment, and surgical approach. [PDF]
Mandelli C +6 more
europepmc +1 more source
Malignant transformation in a patient with type 1 neurofibromatosis: A case report. [PDF]
Li S, Hao W, Xue Y.
europepmc +1 more source
High Allelic Heterogeneity in Kazakhstani Patients with Neurofibromatosis Type 1: Results from the First Molecular Study. [PDF]
Idrissova Z +7 more
europepmc +1 more source
Isolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1. [PDF]
Ouassil S +11 more
europepmc +1 more source
Occipital Bone Defect With Meningoencephalocele and Plexiform Neurofibroma in Neurofibromatosis-1. [PDF]
Pandey A +4 more
europepmc +1 more source
Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1. [PDF]
Clissa PB, Sanabani SS.
europepmc +1 more source
Eruptive Neurofibromas in Pregnancy.
Agrawal I, Muzaffar M, Barman KD.
europepmc +1 more source
Selumetinib Treatment in a Neurofibromatosis Type 1 Child With Second Hit Mutation on the NF1 Gene. [PDF]
Su S +7 more
europepmc +1 more source

